<DOC>
	<DOCNO>NCT00894556</DOCNO>
	<brief_summary>A study provide evidence support benefit Rizatriptan patient inadequate response sumatriptan .</brief_summary>
	<brief_title>A Study Evaluate Efficacy Tolerability Rizatriptan Treatment Acute Migraine ( 0462-087 )</brief_title>
	<detailed_description />
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Sumatriptan</mesh_term>
	<mesh_term>Rizatriptan</mesh_term>
	<criteria>Patient history migraine without aura 1 year 28 moderate severe migraine attack per month Patient generally respond treatment sumatriptan Patient reproductive potential agrees remain abstinent use one method highly effective birth control ( i.e . IUD , condom , hormonal contraceptive , diaphragm , vasectomy ) duration study Patient able complete paper diary Patient pregnant breast feeding except become pregnant study Patient history mild migraine attack migraine usually resolve spontaneously less 2 hour Patient basilar hemiplegic migraine Patient unable distinguish migraine attack type headache Patient 15 headachedays per month Patient great 50 year old age migraine onset Patient fail respond 3 triptans Patient repeat history fail respond tolerate rizatriptan Patient use opioids primary migraine therapy Patient use daily opioids Patient history Cerebrovascular Accident ( CVA ) significant cardiovascular disease Patient uncontrolled hypertension Patient history neoplastic disease Patient take serotonin reuptake inhibitor ( SSRI SNRI ) dose change 3 month prior screen Patient history drug alcohol abuse</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Treatment acute migraine without aura adult</keyword>
</DOC>